Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | TOP2A | P11388 | 1/20 | 0.31 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | GRM5 | P41594 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.30 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Creatinine SCHEMBL7735944 | 0.92 | CRBN (0.50) | CRBNGAATOP2ATOP2BALDH1A1 | |
| Creatinine SCHEMBL15323589 | 0.92 | CRBN (0.40) | CRBNGAA | |
| Creatinine SCHEMBL15732942 | 0.90 | CRBN (0.52) | CRBNGAATOP2ATOP2BALDH1A1 | |
| Creatinine SCHEMBL27811809 | 0.90 | CRBN (0.52) | CRBNGAATOP2ATOP2BALDH1A1 | |
| Creatinine SCHEMBL2248139 | 0.90 | CRBN (0.56) | CRBNGAATOP2ATOP2BALDH1A1 | |
| Creatinine SCHEMBL28491793 | 0.86 | CRBN (0.56) | CRBNGAATOP2ATOP2BALDH1A1 | |
| Creatinine SCHEMBL16295 | 0.86 | — | — | |
| Creatinine SCHEMBL288087 | 0.86 | CRBN (0.61) | CRBNGAATOP2ATOP2BALDH1A1 | |
| Creatinine SCHEMBL8637084 | 0.84 | — | — | |
| Creatinine SCHEMBL2922002 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230201115-A1 | CREATINE AND/OR CREATININE COMPOSITIONS AND RELATED METHODS | THERMOLIFE INTERNATIONAL, LLC | 2023-06-29 | — | — | US | disclosed |
| US-20230062170-A1 | CREATINE AND/OR CREATININE COMPOSITIONS AND RELATED METHODS | THERMOLIFE INTERNATIONAL, LLC | 2023-03-02 | — | — | US | disclosed |
| US-11154499-B2 | Creatine and/or creatinine compositions and related methods | THERMOLIFE INTERNATIONAL, LLC (US) | 2021-10-26 | — | — | US | disclosed |
| US-20210251895-A1 | CREATINE AND/OR CREATININE COMPOSITIONS AND RELATED METHODS | THERMOLIFE INTERNATIONAL, LLC | 2021-08-19 | — | — | US | disclosed |
| US-20200246262-A1 | CREATINE AND/OR CREATININE COMPOSITIONS AND RELATED METHODS | THERMOLIFE INTERNATIONAL, LLC (US) | 2020-08-06 | — | — | US | disclosed |
| WO-2019191338-A1 | CREATINE AND/OR CREATININE COMPOSITIONS AND RELATED METHODS | THERMOLIFE INTERNATIONAL, LLC (US) | 2019-10-03 | — | — | WO | disclosed |
| US-20190298667-A1 | CREATINE AND/OR CREATININE COMPOSITIONS AND RELATED METHODS | THERMOLIFE INTERNATIONAL, LLC | 2019-10-03 | — | — | US | disclosed |
| US-20080146633-A1 | COMPOSITIONS FOR SKIN LIGHTENING AND TONING DOWN PIGMENT DISORDERS, COMPRISING CREATININE AND/OR CREATININE DERIVATIVES AS ACTIVE SUBSTANCES | GOLDSCHMIDT GMBH (DE) | 2008-06-19 | — | — | US | disclosed |
| US-20030180237-A1 | Compositions for skin lightening and toning down pigment disorders, comprising creatinine and/or creatinine derivatives as active substances | GOLDSCHMIDT AG (DE) | 2003-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200246262-A1 | CREATINE AND/OR CREATININE COMPOSITIONS AND RELATED METHODS | MB, CKMT1A; CKMT1B, REN | CRBN 225/4885GAA 806/4885TOP2A 1856/4885 |
| US-11154499-B2 | Creatine and/or creatinine compositions and related methods | MB, CKMT1A; CKMT1B, REN | CRBN 225/4885GAA 806/4885TOP2A 1856/4885 |
| US-20030180237-A1 | Compositions for skin lightening and toning down pigment disorders, comprising creatinine and/or creatinine derivatives as active substances | ALDH1A2, RBP1, ARSA | CRBN 866/4885GAA 1459/4885TOP2A 1038/4885 |
| US-20190298667-A1 | CREATINE AND/OR CREATININE COMPOSITIONS AND RELATED METHODS | CKMT1A; CKMT1B, REN, ALB | CRBN 591/4885GAA 958/4885TOP2A 2692/4885 |
| US-20230201115-A1 | CREATINE AND/OR CREATININE COMPOSITIONS AND RELATED METHODS | CKMT1A; CKMT1B, REN, ALB | CRBN 842/4885GAA 514/4885TOP2A 2223/4885 |
| US-20230062170-A1 | CREATINE AND/OR CREATININE COMPOSITIONS AND RELATED METHODS | CKMT1A; CKMT1B, REN, ALB | CRBN 591/4885GAA 958/4885TOP2A 2692/4885 |
| US-20210251895-A1 | CREATINE AND/OR CREATININE COMPOSITIONS AND RELATED METHODS | MB, CKMT1A; CKMT1B, REN | CRBN 225/4885GAA 806/4885TOP2A 1856/4885 |
| US-20080146633-A1 | COMPOSITIONS FOR SKIN LIGHTENING AND TONING DOWN PIGMENT DISORDERS, COMPRISING CREATININE AND/OR CREATININE DERIVATIVES AS ACTIVE SUBSTANCES | ALDH1A2, REN, ADH1B | CRBN 733/4885GAA 1380/4885TOP2A 1066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.